ArticlePharmaceuticals (Basel, Switzerland)2026
Development and Evaluation of a Novel Inhalable Liposomal Powder Co-Encapsulating ASSNAC and Pirfenidone via Spray Freeze-Drying for Targeted Pulmonary Fibrosis Therapy.
Qinxiu Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.